Depression seriously affects the daily work and life of patients， and leads to a huge financial and medical burden. Non-invasive brain stimulation （NIBS）， as a non-invasive neuromodulation method， has been widely used in the non-drug treatment of depression. Precision medicine is a new trend in biomedical oriented depression diagnosis and treatment. After nearly two decades of rapid development， NIBS is now based on rich data from neuroimaging studies， which allows it to develop personalized interventions from multiple dimensions within a precision medicine framework， such as finding more precise treatment parameter algorithms， focus on brain state goals to expand frequency parameter space and search for evidence of patients' biological subtypes to achieve the purpose of improving patient efficacy. This paper reviews the current NIBS efforts and progress towards precision medicine in the field of depression treatment.